Related Experiment Video

Updated: Jul 14, 2026

Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry
11:54

Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry

Published on: July 13, 2019

A CpG oligodeoxynucleotide inducing anti-coxsackie B3 virus activity in human peripheral blood mononuclear cells

Zhongyi Cong1, Min Wan, Xiuli Wu

  • 1Department of Immunology, College of Basic Medicine, Jilin University, Changchun, China.

FEMS Immunology and Medical Microbiology
|July 5, 2007
PubMed

Insights

BW001, a C-type CpG oligodeoxynucleotide, shows antiviral activity against Coxsackie B3 virus (CVB3) in human cells. This compound stimulates the production of multiple types of interferons (IFNs), suggesting potential for treating CVB3 infections.

Area of Science:

  • Immunology
  • Virology
  • Molecular Biology

Background:

  • Coxsackie B3 virus (CVB3) is a primary cause of human myocarditis.
  • Early antiviral intervention is crucial for effective treatment of CVB3 infections.

Purpose of the Study:

  • To investigate the anti-CVB3 activity of BW001, a C-type CpG oligodeoxynucleotide.
  • To determine if BW001 induces interferon (IFN) production in human peripheral blood mononuclear cells (PBMCs).

Main Methods:

  • Treatment of human PBMCs with BW001.
  • Assessment of anti-CVB3 activity.
  • Measurement of IFN mRNA expression using quantitative PCR.

Main Results:

  • BW001 demonstrated significant anti-CVB3 activity in human PBMCs.
  • BW001 induced the expression of multiple IFN types, including IFN-alpha, IFN-beta, IFN-omega, and IFN-gamma.
  • BW001 upregulated mRNAs for at least 11 subtypes of IFN-alpha.

Conclusions:

  • BW001 exhibits antiviral properties against CVB3.
  • BW001-induced interferons likely contribute to its anti-CVB3 effects.
  • BW001 holds potential as a therapeutic agent for CVB3 infections by stimulating a mixed-interferon response.

More Related Videos

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A1606:03

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Published on: July 15, 2019

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...